Doctor of Philosophy, Case Western Reserve University, 2015, Biomedical Engineering
The growing socioeconomic burden of musculoskeletal injuries resulting in critical-sized bone defects and drawbacks of current therapies have motivated tissue engineering approaches to generate functional tissues to repair bone. This dissertation aimed to develop a readily implantable system to heal bone defects through investigation of the hypothesis that controlled presentation of inductive factors from microparticles to mesenchymal stem cells (MSCs) in high-density culture can guide endochondral bone formation. First, a cartilage template for endochondral ossification was engineered by incorporating TGF-β1-releasing gelatin microparticles (GM) within MSC aggregates and self-assembled sheets. TGF-β1 presentation from GM is predominantly through cell-mediated microparticle degradation with rates tunable by varying polymer crosslinking. Chondrogenesis was shown to be dependent on TGF-β1 concentration and GM amount. Since hydroxyapatite and BMP-2 can regulate chondrogenesis and osteogenesis, their effects on endochondral ossification within MSC aggregates were investigated. Hydroxyapatite was presented in the form of mineral-coated hydroxyapatite microparticles (MCM) capable of controlled BMP-2 delivery. Alone, BMP-2 and MCM induced osteogenesis and chondrogenesis, respectively. Together, BMP-2 and MCM promoted early chondrogenesis followed by additional mineralization, suggesting the induction of endochondral ossification. MSC aggregates were also locally presented with TGF-β1 and BMP-2 by tailoring GM to release the former early for chondrogenic induction and MCM to deliver the latter in a more sustained manner to promote the replacement with bone. Compared to media supplementation, local delivery of TGF-β1 and BMP-2 promoted enhanced chondrogenesis and ALP activity at week 2 and stronger mineralization by week 5. Compared to TGF-β1 or BMP-2 alone, combined treatment resulted in larger mineralized constructs with higher DNA and GAG/DNA content. The ability of thi (open full item for complete abstract)
Committee: Eben Alsberg (Advisor)
Subjects: Biomedical Engineering